Organogenesis Holdings (ORGO) Finished Goods (2021 - 2025)
Organogenesis Holdings has reported Finished Goods over the past 5 years, most recently at $14.0 million for Q4 2025.
- Quarterly results put Finished Goods at $14.0 million for Q4 2025, up 16.43% from a year ago — trailing twelve months through Dec 2025 was $14.0 million (up 16.43% YoY), and the annual figure for FY2025 was $14.0 million, up 16.43%.
- Finished Goods for Q4 2025 was $14.0 million at Organogenesis Holdings, down from $24.4 million in the prior quarter.
- Over the last five years, Finished Goods for ORGO hit a ceiling of $24.4 million in Q3 2025 and a floor of $10.4 million in Q2 2023.
- Median Finished Goods over the past 5 years was $12.8 million (2023), compared with a mean of $13.9 million.
- Biggest five-year swings in Finished Goods: fell 23.51% in 2022 and later surged 87.48% in 2025.
- Organogenesis Holdings' Finished Goods stood at $15.0 million in 2021, then fell by 23.51% to $11.5 million in 2022, then increased by 25.93% to $14.5 million in 2023, then fell by 16.68% to $12.0 million in 2024, then rose by 16.43% to $14.0 million in 2025.
- The last three reported values for Finished Goods were $14.0 million (Q4 2025), $24.4 million (Q3 2025), and $18.3 million (Q2 2025) per Business Quant data.